Haymarket Center

Blog

Medically Assisted Treatment: Responding to the Opioid Crisis

HR HayMarket - Thursday, May 31, 2018

Witnessing the dramatic rise in patients with opioid addiction, Haymarket saw an urgent need to respond to this growing crisis, taking steps to treat patients in an immediate and proven way. The following measures were taken as we:

  • Increased our capacity to provide appropriate medication to individuals in our medical detoxification units.
  • Launched two 16-bed Medicaid certified residential programs, one for men and one for a woman.
  • Used Medication Assisted Treatment (MAT) prescribed by our medical director in both programs.
  • Expanded, providing MAT in our outpatient program, made possible by funding from the City of Chicago.
  • Developed a network of prescribers of Suboxone and naltrexone. As patients step down from residential or outpatient substance use disorder treatment into the community, we can provide effective care coordination so that patients can continue their MAT in the community.

What is the client’s pathway?

At intake, staff nurses or physician assistants

  • Assess the client’s medical and MAT status using a structured interview. This involves an opiate withdrawal protocol, determining prior adherence to medications to help with treatment planning.
  • Conduct a clinical screen, conducted by clinical staff. Because not all patients are appropriate for MAT, the medical and clinical screens help decide which patients are likely to succeed with MAT as an addition to their clinical treatment.
  • Provide education on MAT options available to clients at Haymarket Center. This is conducted by a physician assistant or nurse.

Clients can choose

  • Buprenorphine maintenance therapy prescribed by
    • Haymarket’s medical director. (Haymarket’s medical director is board certified in addiction medicine and certified by SAMHSA and the DEA to prescribe buprenorphine)
    • And/or the project physician assistant, or
    • Elect to receive monthly injections of extended-release naltrexone (VIVITROL) which provides complete blockade of the opioid receptor, preventing the clients from experiencing the euphoric effects of opiates if they should relapse.

With direction from Haymarket’s physician, program nurses or physician assistants monitor medication administration, ensuring clients are taking their medication, monitoring side effects, verifying that clients who choose naltrexone therapy are scheduled for monthly injections.

Staff provides random drug tests, confirming that the clients are not abusing other substances and not diverting buprenorphine.

In addition to the standard treatment group and individual counseling, Haymarket staff implemented the “ Integrating the Twelve Steps with Medication-Assisted Treatment for Opioid Use Disorder.” This evidence-based curriculum helps clients learn more about their conditions and treatment.

Finally, Haymarket Center provides alumni group meetings so current clients can learn that treatment works and, as a result, alumni have ongoing support. These events are typically well attended with an average of 30 or more alumni present.

If you or a loved one are seeking treatment for an addiction, talk to us at Haymarket Center. Call today: (312) 226-7984.

 

Comments
Post has no comments.
Post a Comment




Captcha Image

Trackback Link
http://www.hcenter.org/BlogRetrieve.aspx?BlogID=13700&PostID=731801&A=Trackback
Trackbacks
Post has no trackbacks.

CARF Accrediation | Mental Health First Aid Certified | HIPAA Privacy Statment | IL, DASA, National Outcome Measures

| Priority Admission Statement | Locations


Complete a Stakeholders Survey